杨定一博士专辑
Claim This Podcastby 一如共鸣
Podcast Overview
<p style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;" data-flag="normal"><img data-key="0" src="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" alt="" data-origin="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg?op_type=0" data-large="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-large-width="750" data-large-height="374" data-preview="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-preview-width="140" data-preview-height="69" /><br /></p><p data-flag="normal" style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;">【杨定一博士】：</p><p data-flag="normal" style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;">现任台湾长庚生物科技董事长。美国纽约洛克菲勒康奈尔医学院生化、医学双博士，对T淋巴细胞和杀手细胞如何杀死癌症细胞的发现与研究，写入全世界医学教科书。已有三百多篇医学研究发表在世界顶尖期刊，如《科学》、《细胞》、《自然》、《美国国家科学院院刊》等。</p><p data-flag="normal" style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;">曾任美国国家卫生研究院（NIH）癌症研究所咨询委员，是迄今唯一获得极高荣誉《自由神奖章》的华裔科学家，并被列入美国国会纪录。</p><p style="font-size:16px;line-height:30px;font-family:Helvetica, Arial, sans-serif;color:#333333;font-weight:normal;text-align:justify;" data-flag="normal">杨定一博士的人生堪称由一连串的惊叹号组成：6岁由台湾随父亲移民巴西，13岁考上巴西利亚医学院，21岁取得美国纽约洛克菲勒康奈尔医学院生化、医学双博士，27岁就担任洛克菲勒大学分子免疫及细胞生物学系主任（洛克菲勒大学虽小，却拥有全世界近30位诺贝尔奖得主），最高峰一年在指标性国际科学期刊上发表超过20篇重要科学论文，如《科学》、《细胞》、《自然》、《美国国家科学院院刊》等，这些期刊台湾只要有一篇刊登，都要上报发布新闻，由此可见他的惊人科学成就。2011诺贝尔生理学或医学奖就颁给他在洛克菲勒的好友--当年一起研究不同免疫反应的拉尔夫——斯坦曼医师，可以说杨定一博士的科学成就已达到诺贝尔奖级。<br /></p><p style="font-size:16px;line-height:30px;font-family:Helvetica, Arial, sans-serif;color:#333333;font-weight:normal;text-align:justify;" data-flag="normal"><img data-key="1" src="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" alt="" data-origin="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png?op_type=0" data-large="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-large-width="750" data-large-height="692" data-preview="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-preview-width="140" data-preview-height="129" /><br /></p>
Language
🇨🇳
Publishing Since
7/5/2021
1 verified contact email on file for 杨定一博士专辑
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 17, 2026
《杨定一博士反复提醒的4个重点》
July 10, 2026
杨定一：《信仰已经在等着我们》
July 9, 2026
杨定一：《是心的启发，而不是脑的动机》
1,027 total episodes available
Recent guests on 杨定一博士专辑
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Yang Dingyi
Guest
Yang Ding-Yi
Guest
杨定一
Guest
Dr Yang Dingyi
Guest
Deep-dive analytics for 杨定一博士专辑
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is 杨定一博士专辑?
<p style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;" data-flag="normal"><img data-key="0" src="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" alt="" data-origin="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg?op_type=0" data-large="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-large-width="750" data-large-height="374" data-preview="http://imagev2.xmcdn.com/storages/e2f5-audiofreehighqps/26/8F/GKwRIW4Knsa-AAJpgAMEyhF4.jpg!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-preview-width="140" data-preview-height="69" /><br /></p><p data-flag="normal" style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;">【杨定一博士】：</p><p data-flag="normal" style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;">现任台湾长庚生物科技董事长。美国纽约洛克菲勒康奈尔医学院生化、医学双博士，对T淋巴细胞和杀手细胞如何杀死癌症细胞的发现与研究，写入全世界医学教科书。已有三百多篇医学研究发表在世界顶尖期刊，如《科学》、《细胞》、《自然》、《美国国家科学院院刊》等。</p><p data-flag="normal" style="color:#333333;font-weight:normal;font-size:16px;line-height:30px;font-family:Helvetica,Arial,sans-serif;hyphens:auto;text-align:justify;">曾任美国国家卫生研究院（NIH）癌症研究所咨询委员，是迄今唯一获得极高荣誉《自由神奖章》的华裔科学家，并被列入美国国会纪录。</p><p style="font-size:16px;line-height:30px;font-family:Helvetica, Arial, sans-serif;color:#333333;font-weight:normal;text-align:justify;" data-flag="normal">杨定一博士的人生堪称由一连串的惊叹号组成：6岁由台湾随父亲移民巴西，13岁考上巴西利亚医学院，21岁取得美国纽约洛克菲勒康奈尔医学院生化、医学双博士，27岁就担任洛克菲勒大学分子免疫及细胞生物学系主任（洛克菲勒大学虽小，却拥有全世界近30位诺贝尔奖得主），最高峰一年在指标性国际科学期刊上发表超过20篇重要科学论文，如《科学》、《细胞》、《自然》、《美国国家科学院院刊》等，这些期刊台湾只要有一篇刊登，都要上报发布新闻，由此可见他的惊人科学成就。2011诺贝尔生理学或医学奖就颁给他在洛克菲勒的好友--当年一起研究不同免疫反应的拉尔夫——斯坦曼医师，可以说杨定一博士的科学成就已达到诺贝尔奖级。<br /></p><p style="font-size:16px;line-height:30px;font-family:Helvetica, Arial, sans-serif;color:#333333;font-weight:normal;text-align:justify;" data-flag="normal"><img data-key="1" src="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" alt="" data-origin="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png?op_type=0" data-large="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-large-width="750" data-large-height="692" data-preview="http://imagev2.xmcdn.com/storages/124f-audiofreehighqps/AF/EB/GKwRIUEG377mAARhKwGYbwul.png!op_type=4&device_type=ios&upload_type=attachment&name=mobile_large" data-preview-width="140" data-preview-height="129" /><br /></p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.